StockTipsArenaBeta

Sun Pharmaceutical Industries Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹1,745.1+2.10 (+0.12%)
As of 21 Oct 2026

Avg 1-year target

All 15 long-term calls are BUY

₹2,225.6927.5% above today's price

Sun Pharmaceutical Industries' average 1-year share price target is ₹2,225.69, the average of 13 advisors' latest targets. Targets range from ₹2,070 to ₹2,500.

Latest: HSBC Securities ₹2,100 · 7 Oct 2026

18
18 BUY · 0 SELL, all horizons
13
with an active 1Y target
34%
25 of 74 closed calls hit
93
all horizons, open and closed
Watch SUNPHARMA for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Sun Pharmaceutical Industries target price by brokerage

Each advisor's latest 1-year target · 13 advisors · tap a row for the call

All tips (93)

BUYTarget₹2,100
HSbyHSBC Securities+20.3% to target
1 Year* · 12 mo left · 7 Oct 2026 · entry ₹1,797.1 · via Zee Business (Live)P&L -2.9%
BUYTarget₹2,250
3Oby360 One Capital+28.9% to target
1 Year* · 11 mo left · 29 Sept 2026 · entry ₹1,853.9 · via NDTV ProfitP&L -5.9%
BUYTarget₹2,150
KSbyKotak Securities+23.2% to target
1 Year · 11 mo left · 29 Sept 2026 · entry ₹1,853.9 · via Zee Business (Live)P&L -5.9%
BUYTarget₹2,070
GFbyGeojit Financial Services+18.6% to target
1 Year* · 11 mo left · 21 Sept 2026 · entry ₹1,868.9 · via Moneycontrol Broker ResearchP&L -6.6%
BUYTarget₹2,235
BbyBernstein+28.1% to target
1 Year* · 11 mo left · 2 Sept 2026 · entry ₹1,926.2 · via Zee Business StocksP&L -9.4%
BUYTarget₹2,120
HSbyHSBC Securities+21.5% to target
1 Year* · 11 mo left · 2 Sept 2026 · entry ₹1,910 · via Zee Business (Live)P&L -8.6%
BUYTarget₹2,150
MbyMacquarie+23.2% to target
1 Year* · 10 mo left · 3 Aug 2026 · entry ₹1,983.2 · via CNBC Awaaz.P&L -12.0%
BUYTarget₹2,280
CbyCitigroup+30.7% to target
1 Year* · 10 mo left · 3 Aug 2026 · entry ₹1,983.2 · via ET Now (Live)P&L -12.0%
BUYTarget₹2,310
MObyMotilal Oswal+32.4% to target
1 Year* · 9 mo left · 1 Aug 2026 · entry ₹1,990.5 · via Institutional / Brokerage ResearchP&L -12.3%
BUYTarget₹2,500
SJbySachin Janardan Sarvade, IDBI Capital Markets and Securities+43.3% to target
1 Year* · 9 mo left · 31 Jul 2026 · entry ₹1,983.2 · via NDTV ProfitP&L -12.0%
BUYTarget₹2,500
SBbySudip Bandyopadhyay+43.3% to target
1 Year* · 9 mo left · 31 Jul 2026 · entry ₹1,985.2 · via NDTV ProfitP&L -12.1%
BUYTarget₹2,180
BBbyBajaj Broking+24.9% to target
1 Year* · 9 mo left · 29 Jul 2026 · entry ₹1,971.4 · via Business Standard MarketsP&L -11.5%
BUYTarget₹2,650
MObyMotilal Oswal+51.9% to target
1 Year* · 8 mo left · 23 Jun 2026 · entry ₹1,862.9 · via ET Now (Live)P&L -6.3%
BUYTarget₹2,100
EGbyEmkay Global+20.3% to target
1 Year* · 6 mo left · 28 Apr 2026 · entry ₹1,747.3 · via Institutional / Brokerage ResearchP&L -0.1%
BUYTarget₹2,109
BCbyBOB Capital Markets+20.9% to target
1 Year* · 3 mo left · 1 Feb 2026 · entry ₹1,610.1 · via Institutional / Brokerage ResearchP&L +8.4%
BUYTarget₹2,000
ISbyICICI SecuritiesTarget hit
1 Year* · 28 Apr 2026 · entry ₹1,747.3 · via Institutional / Brokerage Researchexit ₹2,000
BUYTarget₹2,025
MObyMotilal OswalTarget hit
1 Year* · 28 Apr 2026 · entry ₹1,747.3 · via Institutional / Brokerage Researchexit ₹2,025
BUYTarget₹1,900
PLbyPrabhudas LilladherTarget hit
1 Year* · 28 Apr 2026 · entry ₹1,747.3 · via Institutional / Brokerage Researchexit ₹1,900
BUYTarget₹1,899
GFbyGeojit Financial ServicesTarget hit
1 Year* · 17 Feb 2026 · entry ₹1,717.1 · via Institutional / Brokerage Researchexit ₹1,899
BUYTarget₹1,910
ISbyICICI SecuritiesTarget hit
1 Year* · 1 Feb 2026 · entry ₹1,610.1 · via Institutional / Brokerage Researchexit ₹1,910
BUYTarget₹1,940
MObyMotilal OswalTarget hit
1 Year* · 31 Jan 2026 · entry ₹1,640 · via Institutional / Brokerage Researchexit ₹1,940
BUYTarget₹2,000
EGbyEmkay GlobalTarget hit
1 Year* · 6 Nov 2025 · entry ₹1,685.9 · via Institutional / Brokerage Researchexit ₹2,000
BUYTarget₹1,965
ISbyICICI SecuritiesTarget hit
1 Year* · 6 Nov 2025 · entry ₹1,685.9 · via Institutional / Brokerage Researchexit ₹1,965
BUYTarget₹1,830
GFbyGeojit Financial ServicesTarget hit
1 Year* · 5 Aug 2025 · entry ₹1,632.1 · via Institutional / Brokerage Researchexit ₹1,830
BUYTarget₹2,003
BCbyBOB Capital MarketsTarget hit
1 Year* · 1 Aug 2025 · entry ₹1,629.7 · via Institutional / Brokerage Researchexit ₹2,003
BUYTarget₹1,875
PLbyPrabhudas LilladherTarget hit
1 Year* · 1 Aug 2025 · entry ₹1,629.7 · via Institutional / Brokerage Researchexit ₹1,875
BUYTarget₹1,960
MObyMotilal OswalTarget hit
1 Year* · 31 Jul 2025 · entry ₹1,706.7 · via Institutional / Brokerage Researchexit ₹1,960
BUYTarget₹1,800
SRbySharekhan ResearchTarget hit
1 Year* · 20 Jun 2024 · entry ₹1,471 · via Institutional / Brokerage Researchexit ₹1,800
BUYTarget₹1,810
MObyMotilal OswalTarget hit
1 Year* · 22 May 2024 · entry ₹1,539.3 · via Institutional / Brokerage Researchexit ₹1,810
BUYTarget₹1,870
MObyMotilal OswalTarget hit
1 Year* · 23 Apr 2024 · entry ₹1,484.65 · via Institutional / Brokerage Researchexit ₹1,870
BUYTarget₹1,727
SRbySharekhan ResearchTarget hit
1 Year* · 11 Mar 2024 · entry ₹1,593.6 · via Institutional / Brokerage Researchexit ₹1,727
BUYTarget₹2,100
SMbySomil Mehta, SharekhanStop-loss hit
1 Year · 1 Sept 2026 · entry ₹1,936.1 · via NDTV Profitexit ₹1,868
BUYTarget₹1,993
BCbyBOB Capital MarketsExpired
1 Year* · 23 May 2025 · entry ₹1,683.6 · via Institutional / Brokerage Researchexit ₹1,844.6
BUYTarget₹2,000
PLbyPrabhudas LilladherExpired
1 Year* · 23 May 2025 · entry ₹1,683.6 · via Institutional / Brokerage Researchexit ₹1,844.6
BUYTarget₹1,895
ISbyICICI SecuritiesExpired
1 Year* · 11 Mar 2025 · entry ₹1,655.3 · via Institutional / Brokerage Researchexit ₹1,825.9
BUYTarget₹2,086
BCbyBOB Capital MarketsExpired
1 Year* · 1 Feb 2025 · entry ₹1,742.2 · via Institutional / Brokerage Researchexit ₹1,595.3
BUYTarget₹2,400
EGbyEmkay GlobalExpired
1 Year* · 21 Jan 2025 · entry ₹1,762.7 · via Institutional / Brokerage Researchexit ₹1,612.9
BUYTarget₹2,185
ISbyICICI SecuritiesExpired
1 Year* · 29 Oct 2024 · entry ₹1,871.6 · via Institutional / Brokerage Researchexit ₹1,715.9
BUYTarget₹2,264
SRbySharekhan ResearchExpired
1 Year* · 28 Oct 2024 · entry ₹1,902.9 · via Institutional / Brokerage Researchexit ₹1,687
BUYTarget₹1,980
MObyMotilal OswalExpired
1 Year* · 1 Aug 2024 · entry ₹1,715.2 · via Institutional / Brokerage Researchexit ₹1,629.7
BUYTarget₹2,100
ABbyArpit Beriwal, Motilal Oswal+20.3% to target
1–3 Months · 9d left · 30 Jul 2026 · entry ₹2,016.4 · via ET NowP&L -13.5%
BUYTarget₹2,200
SCbyShrikant Chouhan, Kotak Securities+26.1% to target
1–3 Months · 9d left · 30 Jul 2026 · entry ₹2,002.8 · via Zee Business (Live)P&L -12.9%
BUYTarget₹2,200
GSbyGaurav Sharma, Globe Capital Market+26.1% to target
1–3 Months · 6d left · 27 Jul 2026 · entry ₹1,948.2 · via NDTV ProfitP&L -10.4%
SELLTarget₹1,720
RPbyRajesh Palviya, Axis SecuritiesStop-loss hit
1–3 Months · 5 Oct 2026 · entry ₹1,775 · via CNBC Awaaz.exit ₹1,800
BUYTarget₹1,920
SSbySandip SabharwalStop-loss hit
1–3 Months · 23 Sept 2026 · entry ₹1,851.3 · via ET Now (Live)exit ₹1,825
BUYTarget₹1,960
ABbyAshish Bahety, Profitmart SecuritiesStop-loss hit
1–3 Months* · 30 Jun 2026 · entry ₹1,891.9 · via CNBC Awaaz.exit ₹1,860
BUYTarget₹2,120
HSbyHDFC SecuritiesExpired
1–3 Months* · 13 Jul 2026 · entry ₹1,933.65 · via Economic Times New Stock Recosexit ₹1,770.7
BUYTarget₹1,950
ABbyAshish Bahety, Profitmart SecuritiesTarget hit
1–2 Weeks* · 31 Aug 2026 · entry ₹1,926.5 · via CNBC Awaaz.exit ₹1,950
BUYTarget₹1,960
VSbyVikas Salunkhe, Nirmal Bang SecuritiesTarget hit
1–2 Weeks* · 19 Aug 2026 · entry ₹1,892.6 · via CNBC Awaaz.exit ₹1,960
BUYTarget₹1,950
SMbySomil Mehta, SharekhanTarget hit
1–2 Weeks* · 29 Jun 2026 · entry ₹1,893 · via CNBC Awaaz.exit ₹1,950

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Full call history, all horizons: page 2 of 2

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks